PTGX
Protagonist Therapeutics, Inc
+0.84 (+0.59%)143.68USD137K成交股數9.3B市值139.5本益比(近四季)33.0股價營收比+3749.2%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 6 · 34.2M · 2 |
| 其中 10b5-1 計畫賣出 | 6 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 69.4M |
| 近 180 天 淨額 | −69.4M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | 09-10 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 7.3K | 144.10 | 1.0M | 523K | SEC |
| 2026-09-10 | 09-10 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 7.3K | 21.58 | 157K | 530K | SEC |
| 2026-09-09 | 09-10 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 63.5K | 21.58 | 1.4M | 587K | SEC |
| 2026-09-09 | 09-10 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 63.5K | 146.18 | 9.3M | 523K | SEC |
| 2026-09-08 | 09-10 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 54.2K | 21.58 | 1.2M | 577K | SEC |
| 2026-09-08 | 09-10 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 54.2K | 145.87 | 7.9M | 523K | SEC |
| 2026-09-03 | 09-08 | PATEL DINESH V PH D | President and CEO | G 贈與 | 510 | – | – | 523K | SEC |
| 2026-08-11 | 08-12 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 34.2K | 148.52 | 5.1M | 523K | SEC |
| 2026-08-11 | 08-12 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 34.2K | 21.58 | 739K | 558K | SEC |
| 2026-08-10 | 08-12 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 65.8K | 21.58 | 1.4M | 589K | SEC |
| 2026-08-10 | 08-12 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 65.8K | 149.11 | 9.8M | 523K | SEC |
| 2026-06-23 | 06-25 | Waddill William D. | Director | M 選擇權執行 | 9.0K | 16.54 | 149K | 16.8K | SEC |
| 2026-06-23 | 06-25 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 9.0K | 117.94 | 1.1M | 7.8K | SEC |
| 2026-06-10 | 06-11 | Waddill William D. | Director | M 選擇權執行 | 6.0K | 16.54 | 99K | 16.8K | SEC |
| 2026-06-10 | 06-11 | Waddill William D. | Director | M 選擇權執行 | 3.0K | 11.80 | 35K | 10.8K | SEC |
| 2026-06-10 | 06-11 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 9.0K | 107.68 | 969K | 7.8K | SEC |
| 2026-05-29 | 06-01 | Waddill William D. | Director | M 選擇權執行 | 9.0K | 11.80 | 106K | 16.8K | SEC |
| 2026-05-29 | 06-01 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 9.0K | 99.64 | 897K | 7.8K | SEC |
| 2026-05-12 | 05-14 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 75.0K | 21.58 | 1.6M | 598K | SEC |
| 2026-05-12 | 05-14 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出(10b5-1) | 75.0K | 100.12 | 7.5M | 523K | SEC |
| 2026-05-12 | 05-12 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 75.0K | 100.12 | 7.5M | 523K | SEC |
| 2026-05-12 | 05-12 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 75.0K | 21.58 | 1.6M | 598K | SEC |
| 2026-05-08 | 05-11 | Giraudo Bryan | Director | S 公開市場賣出 | 5.1K | 100.00 | 513K | 12.7K | SEC |
| 2026-05-08 | 05-11 | Giraudo Bryan | Director | S 公開市場賣出 | 6.0K | 100.00 | 600K | 0 | SEC |
| 2026-05-07 | 05-11 | Giraudo Bryan | Director | M 選擇權執行 | 24.0K | 6.45 | 155K | 31.8K | SEC |
| 2026-05-07 | 05-11 | Giraudo Bryan | Director | S 公開市場賣出 | 12.0K | 100.07 | 1.2M | 6.0K | SEC |
| 2026-05-07 | 05-11 | Giraudo Bryan | Director | M 選擇權執行 | 12.0K | 6.98 | 84K | 43.8K | SEC |
| 2026-05-07 | 05-11 | Giraudo Bryan | Director | S 公開市場賣出 | 36.0K | 100.14 | 3.6M | 27.8K | SEC |
| 2026-04-23 | 04-24 | PATEL DINESH V PH D | President and CEO | G 贈與 | 1.5K | – | – | 523K | SEC |
| 2026-04-20 | 04-21 | Ali Asif | Chief Financial Officer | S 公開市場賣出 | 1.8K | 105.47 | 185K | 59.0K | SEC |
| 2026-03-26 | 03-27 | MOLINA ARTURO MD | Chief Medical Officer | M 選擇權執行 | 15.0K | 8.04 | 121K | 99.1K | SEC |
| 2026-03-26 | 03-27 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 15.0K | 104.79 | 1.6M | 84.1K | SEC |
| 2026-03-26 | 03-27 | Ali Asif | Chief Financial Officer | M 選擇權執行 | 5.3K | 12.17 | 64K | 85.5K | SEC |
| 2026-03-26 | 03-27 | SELICK HAROLD E | Director | S 公開市場賣出 | 24.0K | 105.00 | 2.5M | 60.8K | SEC |
| 2026-03-26 | 03-27 | Ali Asif | Chief Financial Officer | M 選擇權執行 | 19.5K | 19.19 | 374K | 80.3K | SEC |
| 2026-03-26 | 03-27 | Ali Asif | Chief Financial Officer | S 公開市場賣出 | 24.8K | 104.24 | 2.6M | 60.8K | SEC |
| 2026-03-26 | 03-27 | SELICK HAROLD E | Director | M 選擇權執行 | 24.0K | 12.88 | 309K | 84.8K | SEC |
| 2026-03-25 | 03-25 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 54.6K | 101.00 | 5.5M | 525K | SEC |
| 2026-03-25 | 03-25 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 54.6K | 8.58 | 469K | 580K | SEC |
| 2026-03-24 | 03-25 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 59 | 8.58 | 506.22 | 525K | SEC |
| 2026-03-24 | 03-25 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 59 | 101.00 | 6K | 525K | SEC |
| 2026-03-23 | 03-25 | PATEL DINESH V PH D | President and CEO | G 贈與 | 50.0K | – | – | 525K | SEC |
| 2026-02-17 | 02-18 | Williams Lewis T | Director | S 公開市場賣出 | 18.0K | 82.42 | 1.5M | 7.8K | SEC |
| 2026-02-17 | 02-18 | Williams Lewis T | Director | M 選擇權執行 | 18.0K | 10.84 | 195K | 25.8K | SEC |
| 2026-02-06 | 02-06 | Waddill William D. | Director | S 公開市場賣出 | 20.0K | 83.68 | 1.7M | 7.8K | SEC |
| 2026-02-06 | 02-06 | Waddill William D. | Director | M 選擇權執行 | 20.0K | 8.31 | 166K | 27.8K | SEC |
| 2026-01-27 | 01-27 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 4.1K | 21.58 | 88K | 579K | SEC |
| 2026-01-27 | 01-27 | Ali Asif | Chief Financial Officer | S 公開市場賣出 | 28.0K | 83.13 | 2.3M | 78.5K | SEC |
| 2026-01-27 | 01-27 | Ali Asif | Chief Financial Officer | M 選擇權執行 | 12.0K | 12.17 | 146K | 107K | SEC |
| 2026-01-27 | 01-27 | Ali Asif | Chief Financial Officer | M 選擇權執行 | 16.0K | 19.19 | 307K | 94.5K | SEC |
| 2026-01-27 | 01-27 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 5.0K | 82.00 | 410K | 84.1K | SEC |
| 2026-01-27 | 01-27 | MOLINA ARTURO MD | Chief Medical Officer | M 選擇權執行 | 5.0K | 8.04 | 40K | 89.1K | SEC |
| 2026-01-27 | 01-27 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 4.1K | 83.19 | 338K | 575K | SEC |
| 2026-01-27 | 01-27 | Ali Asif | Chief Financial Officer | S 公開市場賣出 | 18.2K | 83.14 | 1.5M | 60.3K | SEC |
| 2026-01-26 | 01-27 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 14.2K | 84.05 | 1.2M | 575K | SEC |
| 2026-01-26 | 01-27 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 14.2K | 21.58 | 307K | 589K | SEC |
| 2026-01-26 | 01-27 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 10.7K | 84.00 | 898K | 575K | SEC |
| 2026-01-26 | 01-27 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 10.7K | 4.21 | 45K | 585K | SEC |
| 2026-01-26 | 01-27 | MOLINA ARTURO MD | Chief Medical Officer | M 選擇權執行 | 5.0K | 8.04 | 40K | 89.1K | SEC |
| 2026-01-26 | 01-27 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 5.0K | 82.28 | 411K | 84.1K | SEC |
| 2026-01-23 | 01-27 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 19.3K | 84.59 | 1.6M | 575K | SEC |
| 2026-01-23 | 01-27 | PATEL DINESH V PH D | President and CEO | M 選擇權執行 | 19.3K | 4.21 | 81K | 594K | SEC |
| 2026-01-23 | 01-27 | PATEL DINESH V PH D | President and CEO | G 贈與 | 6.0K | – | – | 575K | SEC |
| 2026-01-23 | 01-27 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 13.2K | 82.42 | 1.1M | 84.1K | SEC |
| 2026-01-20 | 01-21 | PATEL DINESH V PH D | President and CEO | S 公開市場賣出 | 34.4K | 82.48 | 2.8M | 581K | SEC |
| 2026-01-20 | 01-21 | Ali Asif | Chief Financial Officer | S 公開市場賣出 | 8.6K | 82.48 | 708K | 78.1K | SEC |
| 2026-01-20 | 01-21 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 9.5K | 82.48 | 785K | 97.3K | SEC |
| 2026-01-09 | 01-13 | SELICK HAROLD E | Director | M 選擇權執行 | 14.3K | 4.21 | 60K | 60.8K | SEC |
| 2026-01-02 | 01-06 | PATEL DINESH V PH D | President and CEO | A 獲配股票 | 95.4K | – | – | 615K | SEC |
| 2026-01-02 | 01-06 | SELICK HAROLD E | Director | A 獲配股票 | 2.7K | – | – | 46.5K | SEC |
| 2026-01-02 | 01-06 | Ali Asif | Chief Financial Officer | A 獲配股票 | 25.6K | – | – | 86.7K | SEC |
| 2026-01-02 | 01-06 | Waddill William D. | Director | A 獲配股票 | 2.7K | – | – | 7.8K | SEC |
| 2026-01-02 | 01-06 | Giraudo Bryan | Director | A 獲配股票 | 2.7K | – | – | 17.8K | SEC |
| 2026-01-02 | 01-06 | Williams Lewis T | Director | A 獲配股票 | 2.7K | – | – | 7.8K | SEC |
| 2026-01-02 | 01-06 | MOLINA ARTURO MD | Chief Medical Officer | A 獲配股票 | 25.6K | – | – | 107K | SEC |
| 2026-01-02 | 01-06 | O'Dowd Sarah A | Director | A 獲配股票 | 2.7K | – | – | 7.8K | SEC |
| 2025-11-21 | 11-24 | PATEL DINESH V PH D | President and CEO | G 贈與 | 440 | – | – | 520K | SEC |
| 2025-11-17 | 11-19 | MOLINA ARTURO MD | Chief Medical Officer | S 公開市場賣出 | 2.7K | 84.77 | 230K | 81.2K | SEC |
| 2025-10-10 | 10-14 | Waddill William D. | Director | S 公開市場賣出(10b5-1) | 4.0K | 69.25 | 277K | 13.1K | SEC |
| 2025-10-10 | 10-14 | Waddill William D. | Director | M 選擇權執行 | 12.0K | 6.98 | 84K | 17.1K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 10.3M | 1.3B | +528K (+5%) | 加碼 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 6.3M | 778M | 不變 | 持平 |
| RTW INVESTMENTS, LP | 5.1M | 620M | +2.1K (+0%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | 445M | +148K (+4%) | 加碼 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.4M | 419M | −183K (-5%) | 減碼 |
| UBS Group AG | 3.4M | 417M | −1.8M (-34%) | 減碼 |
| STATE STREET CORP | 3.3M | 407M | +205K (+7%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | 350M | +47.5K (+2%) | 加碼 |
| JOHNSON & JOHNSON | 2.4M | 300M | 不變 | 持平 |
| Invesco Ltd. | 2.3M | 287M | +176K (+8%) | 加碼 |
| Jupiter Topco LLC | 2.1M | 261M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | 213M | +71.8K (+4%) | 加碼 |
| Woodline Partners LP | 1.4M | 173M | 不變 | 持平 |
| BANK OF AMERICA CORP /DE/ | 1.3M | 162M | +29.1K (+2%) | 加碼 |
| JENNISON ASSOCIATES LLC | 1.2M | 141M | +79.7K (+7%) | 加碼 |
| PERCEPTIVE ADVISORS LLC | 982K | 120M | −249K (-20%) | 減碼 |
| ADAR1 Capital Management, LLC | 961K | 118M | −33.3K (-3%) | 減碼 |
| MORGAN STANLEY | 906K | 111M | −112K (-11%) | 減碼 |
| Alyeska Investment Group, L.P. | 889K | 109M | +296K (+50%) | 加碼 |
| Hood River Capital Management LLC | 883K | 108M | +53.5K (+6%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 813K | 99.6M | +33.9K (+4%) | 加碼 |
| Driehaus Capital Management LLC | 731K | 89.6M | +10.1K (+1%) | 加碼 |
| Clearbridge Investments, LLC | 725K | 88.9M | +104K (+17%) | 加碼 |
| FMR LLC | 672K | 82.4M | +10.2K (+2%) | 加碼 |
| NORTHERN TRUST CORP | 666K | 81.7M | +78.1K (+13%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 344 +23 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 63 / 40 / 130 / 78 |
| 機構合計持股 · 佔流通股 | 75.8M · 100.0% |
| 合計季末市值 | 8.9B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 7.7M |
|---|---|
| 與上期比 | -1.0% |
| 佔流通股數 | 11.92% |
| 日均成交量 | 503K |
| 回補天數 | 15.3 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 7.7M | -1.0% | 11.92% | 503K | 15.3 |
| 2026-08-14 | 7.8M | +3.3% | 12.04% | 475K | 16.4 |
| 2026-07-31 | 7.5M | -9.0% | 11.66% | 531K | 14.2 |
| 2026-07-15 | 8.3M | +7.8% | 12.82% | 870K | 9.5 |
| 2026-06-30 | 7.7M | -0.5% | 11.89% | 1.1M | 7.2 |
| 2026-06-15 | 7.7M | +4.3% | 11.94% | 667K | 11.6 |
| 2026-05-29 | 7.4M | +1.6% | 11.45% | 441K | 16.8 |
| 2026-05-15 | 7.3M | -3.3% | 11.27% | 572K | 12.8 |
| 2026-04-30 | 7.5M | -10.2% | 11.65% | 635K | 11.9 |
| 2026-04-15 | 8.4M | -2.7% | 12.98% | 723K | 11.6 |
| 2026-03-31 | 8.6M | +7.0% | 13.33% | 1.1M | 7.6 |
| 2026-03-13 | 8.1M | -1.6% | 12.46% | 741K | 10.9 |
| 2026-02-27 | 8.2M | -3.0% | 12.66% | 497K | 16.5 |
| 2026-02-13 | 8.4M | +3.8% | 13.05% | 635K | 13.3 |
| 2026-01-30 | 8.1M | -2.0% | 12.57% | 770K | 10.6 |
| 2026-01-15 | 8.3M | +13.8% | 12.82% | 949K | 8.8 |
| 2025-12-31 | 7.3M | +11.5% | 11.27% | 767K | 9.5 |
| 2025-12-15 | 6.5M | +11.2% | 10.11% | 1.1M | 6.0 |
| 2025-11-28 | 5.9M | +5.4% | 9.09% | 833K | 7.1 |
| 2025-11-14 | 5.6M | +2.1% | 8.63% | 955K | 5.9 |
| 2025-10-31 | 5.5M | -13.4% | 8.45% | 976K | 5.6 |
| 2025-10-15 | 6.3M | -5.0% | 9.75% | 1.9M | 3.3 |
| 2025-09-30 | 6.6M | -0.3% | 10.26% | 1.2M | 5.6 |
| 2025-09-15 | 6.7M | -2.7% | 10.29% | 1.2M | 5.8 |
| 2025-08-29 | 6.8M | +8.5% | 10.58% | 687K | 10.0 |
| 2025-08-15 | 6.3M | +9.6% | 9.75% | 632K | 10.0 |